Quantitative structure-activity relationship (QSAR) methodology in forensic toxicology: Modeling postmortem redistribution of structurally diverse drugs using multivariate statistics

被引:14
作者
Giaginis, Costas [1 ,2 ]
Tsantili-Kakoulidou, Anna [2 ]
Theocharis, Stamatios [1 ]
机构
[1] Univ Athens, Sch Med, Dept Forens Med & Toxicol, GR-11527 Athens, Greece
[2] Univ Athens, Dept Pharmaceut Chem, Sch Pharm, GR-15771 Athens, Greece
关键词
Forensic toxicology; Postmortem redistribution; QSAR; Multivariate data analysis; Physicochemical properties; Molecular properties; BASIC DRUGS; BLOOD; SITE;
D O I
10.1016/j.forsciint.2009.05.003
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Postmortem redistribution (PMR) constitutes a multifaceted process, which renders the analytical results of drug concentrations inaccurate to be interpreted by forensic toxicologists. The aim of the present study was to evaluate whether quantitative structure-activity relationship (QSAR) methodology could serve as an effective tool to estimate the ability of drugs to redistribute across tissue barriers during postmortem period on the basis of their molecular, physicochemical and structural properties. In this aspect, multivariate data analysis (MVDA) was applied to a set of 77 structurally diverse drugs. PMR data expressed by the central: peripheral concentration ratio (C:P ratio) was taken from the literature. An adequate and robust QSAR model (R-2 = 0.65, Q(2) = 0.56, RMSEE = 0.34) was established for 59 (77%) out of 77 drugs. Although the derived QSAR model presented limited applicability, it provided an informative illustration of the contributing molecular, physicochemical and structural properties in PMR process. Drugs with strong basic properties and enhanced molecular size, flexibility, lipophilicity, and number of halogens were found to be susceptible to increased PMR. Due to the high complexity of PMR process, further QSAR studies need to focus on structurally related drugs to develop more specific models, which could serve as alternative tools to evaluate PMR for different chemical classes. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 32 条
  • [1] [Anonymous], MULTI AND MEGAVARIAT
  • [2] CONCENTRATIONS OF BASIC DRUGS IN POSTMORTEM HUMAN MYOCARDIUM
    BAILEY, DN
    SHAW, RF
    [J]. JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1982, 19 (02): : 197 - 202
  • [3] Barnhart F E, 2001, Forensic Sci Rev, V13, P101
  • [4] Recent advances in high throughput screening for ADME properties
    Carlson, Timothy J.
    Fisher, Michael B.
    [J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2008, 11 (03) : 258 - 264
  • [5] Estimating antemortem drug concentrations from postmortem blood samples: the influence of postmortem redistribution
    Cook, DS
    Braithwaite, RA
    Hale, KA
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (04) : 282 - 285
  • [6] Dalpe-Scott M., 1995, Can. Soc. Forensic Sci. J, V28, P113, DOI DOI 10.1080/00085030.1995.10757474
  • [7] Postmortem drug analysis: Analytical and toxicological aspects
    Drummer, OH
    Gerostamoulos, J
    [J]. THERAPEUTIC DRUG MONITORING, 2002, 24 (02) : 199 - 209
  • [8] Post-mortem toxicology
    Drummer, Olaf H.
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2007, 165 (2-3) : 199 - 203
  • [9] Multivariate design and modeling in QSAR
    Eriksson, L
    Johansson, E
    [J]. CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1996, 34 (01) : 1 - 19
  • [10] Post-mortem clinical pharmacology
    Ferner, R. E.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (04) : 430 - 443